Literature DB >> 25013158

Case definition: postartemisinin delayed hemolysis.

Paul M Arguin1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25013158      PMCID: PMC4093673          DOI: 10.1182/blood-2014-06-578922

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  A comparison of the in vivo kinetics of Plasmodium falciparum ring-infected erythrocyte surface antigen-positive and -negative erythrocytes.

Authors:  P N Newton; K Chotivanich; W Chierakul; R Ruangveerayuth; P Teerapong; K Silamut; S Looareesuwan; N J White
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

2.  Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins.

Authors:  Stéphane Jauréguiberry; Papa A Ndour; Camille Roussel; Flavie Ader; Innocent Safeukui; Marie Nguyen; Sylvestre Biligui; Liliane Ciceron; Oussama Mouri; Eric Kendjo; François Bricaire; Muriel Vray; Adéla Angoulvant; Julien Mayaux; Kasturi Haldar; Dominique Mazier; Martin Danis; Eric Caumes; Marc Thellier; Pierre Buffet
Journal:  Blood       Date:  2014-05-23       Impact factor: 22.113

3.  The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria.

Authors:  K Chotivanich; R Udomsangpetch; A Dondorp; T Williams; B Angus; J A Simpson; S Pukrittayakamee; S Looareesuwan; C I Newbold; N J White
Journal:  J Infect Dis       Date:  2000-07-28       Impact factor: 5.226

4.  Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.

Authors:  Arjen Dondorp; François Nosten; Kasia Stepniewska; Nick Day; Nick White
Journal:  Lancet       Date:  2005 Aug 27-Sep 2       Impact factor: 79.321

Review 5.  Intravenous artesunate for the treatment of severe malaria.

Authors:  Karl M Hess; Jeffery A Goad; Paul M Arguin
Journal:  Ann Pharmacother       Date:  2010-06-15       Impact factor: 3.154

6.  Haemolytic anaemia after oral artemether-lumefantrine treatment in a patient affected by severe imported falciparum malaria.

Authors:  P De Nardo; A Oliva; M L Giancola; P Ghirga; P Mencarini; M Bibas; E Nicastri; A Antinori; A Corpolongo
Journal:  Infection       Date:  2013-04-04       Impact factor: 3.553

7.  Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria--a double-center prospective study.

Authors:  Thierry Rolling; Tsiri Agbenyega; Saadou Issifou; Ayola Akim Adegnika; Justice Sylverken; Dorothee Spahlinger; Daniel Ansong; Sascha J Z Löhr; Gerd D Burchard; Jürgen May; Benjamin Mordmüller; Sanjeev Krishna; Peter G Kremsner; Jakob P Cramer
Journal:  J Infect Dis       Date:  2013-12-26       Impact factor: 5.226

8.  Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Authors:  Arjen M Dondorp; Caterina I Fanello; Ilse C E Hendriksen; Ermelinda Gomes; Amir Seni; Kajal D Chhaganlal; Kalifa Bojang; Rasaq Olaosebikan; Nkechinyere Anunobi; Kathryn Maitland; Esther Kivaya; Tsiri Agbenyega; Samuel Blay Nguah; Jennifer Evans; Samwel Gesase; Catherine Kahabuka; George Mtove; Behzad Nadjm; Jacqueline Deen; Juliet Mwanga-Amumpaire; Margaret Nansumba; Corine Karema; Noella Umulisa; Aline Uwimana; Olugbenga A Mokuolu; Olanrewaju T Adedoyin; Wahab B R Johnson; Antoinette K Tshefu; Marie A Onyamboko; Tharisara Sakulthaew; Wirichada Pan Ngum; Kamolrat Silamut; Kasia Stepniewska; Charles J Woodrow; Delia Bethell; Bridget Wills; Martina Oneko; Tim E Peto; Lorenz von Seidlein; Nicholas P J Day; Nicholas J White
Journal:  Lancet       Date:  2010-11-07       Impact factor: 79.321

9.  Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria--worldwide, 2010-2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-01-11       Impact factor: 17.586

  9 in total
  10 in total

1.  Development of Delayed Hemolytic Anemia After Treatment with Oral Artemether-Lumefantrine in Two Patients with Severe Falciparum Malaria.

Authors:  Yasuhiro Tsuchido; Fukumi Nakamura-Uchiyama; Kasumi Toyoda; Moritoshi Iwagami; Kentaro Tochitani; Koh Shinohara; Naokuni Hishiya; Taku Ogawa; Kenji Uno; Kei Kasahara; Yukiteru Ouji; Shigeyuki Kano; Keiichi Mikasa; Tsunehiro Shimizu; Masahide Yoshikawa; Haruhiko Maruyama
Journal:  Am J Trop Med Hyg       Date:  2017-02-13       Impact factor: 2.345

2.  Surveillance for the safety and effectiveness of artemether-lumefantrine in patients with uncomplicated Plasmodium falciparum malaria in the USA: a descriptive analysis.

Authors:  Alyson M Gray; Paul M Arguin; Kamal Hamed
Journal:  Malar J       Date:  2015-09-17       Impact factor: 2.979

3.  Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria.

Authors:  Florian Kurth; Tilman Lingscheid; Florian Steiner; Miriam S Stegemann; Sabine Bélard; Nikolai Menner; Peter Pongratz; Johanna Kim; Horst von Bernuth; Beate Mayer; Georg Damm; Daniel Seehofer; Abdulgabar Salama; Norbert Suttorp; Thomas Zoller
Journal:  Emerg Infect Dis       Date:  2016-08       Impact factor: 6.883

4.  Systematic analysis of direct antiglobulin test results in post-artesunate delayed haemolysis.

Authors:  Tommaso Ascoli Bartoli; Luciana Lepore; Alessandra D'Abramo; Giovanna Adamo; Angela Corpolongo; Laura Scorzolini; Maria Letizia Giancola; Nazario Bevilacqua; Claudia Palazzolo; Andrea Mariano; Giuseppe Ippolito; Pierre Buffet; Emanuele Nicastri
Journal:  Malar J       Date:  2021-04-29       Impact factor: 2.979

5.  Severe falciparum malaria complicated by prolonged haemolysis and rhinomaxillary mucormycosis after parasite clearance: a case report.

Authors:  Katherine Plewes; Richard J Maude; Aniruddha Ghose; Arjen M Dondorp
Journal:  BMC Infect Dis       Date:  2015-12-03       Impact factor: 3.090

6.  Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.

Authors:  Akintunde Sowunmi; Kazeem Akano; Adejumoke I Ayede; Godwin Ntadom; Temitope Aderoyeje; Elsie O Adewoye; Bayo Fatunmbi
Journal:  BMC Infect Dis       Date:  2016-06-01       Impact factor: 3.090

7.  Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children.

Authors:  Akintunde Sowunmi; Kazeem Akano; Adejumoke I Ayede; Godwin Ntadom; Bayo Fatunmbi; Temitope Aderoyeje; Elsie O Adewoye
Journal:  BMC Infect Dis       Date:  2015-10-26       Impact factor: 3.090

8.  Artesunate treatment of severe pediatric malaria: A review of parasite clearance kinetics and clinical implications.

Authors:  Michael T Hawkes; Sarah Forgie; Jason Brophy; Maryanne Crockett
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Sep-Oct       Impact factor: 2.471

9.  Update on cases of delayed hemolysis after parenteral artesunate therapy for malaria - United States, 2008 and 2013.

Authors:  Magdalena M Paczkowski; Keren L Landman; Paul M Arguin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-08-29       Impact factor: 17.586

10.  Treatment for Severe Malaria: Post-Artesunate Delayed Haemolysis and Neutropenia.

Authors:  Mariangela Martino; Cecilia Liberati; Benedetta Bua; Elisa Barbieri; Paola Costenaro; Costanza Di Chiara; Carlo Giaquinto; Ettore De Canale; Osvalda Rampon; Daniele Donà
Journal:  Healthcare (Basel)       Date:  2022-02-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.